Menu

Image of the Day: 3-D Nanofibers

Researchers created a nanofibrous scaffold to see how it supports cell growth.

Mar 7, 2018
The Scientist Staff, The Scientist Staff

Cardiac muscle cells (purple) envelop a 3-D model of nanofibers (pink). V. BALASHOV ET AL.

Researchers at the Moscow Institute of Physics and Technology (MIPT) created a 3-D model of synthetic nanofibers to learn how to engineer more efficient scaffolds for biomedical applications. The researchers reported in Acta Biomaterialia last week (March 2) that cardiac muscle cells, called cardiomyocytes, interface with nanofibers differently than do fibroblasts—connective tissue cells.

“[W]e discovered that during their development on a nanofibrous scaffold, cardiomyocytes wrap the fibers on all sides creating a ‘sheath’ structure in the majority of cases,” says study coauthor Konstantin Agladze, a physicist at MIPT, in a press release. “Fibroblasts, by contrast, have a more rigid structure and a much smaller area of interaction with the substrate, touching it only on one side.” This finding could help scientists engineer more effective nanofiber scaffolds for “smart” biomaterials, the researchers write in the study.

V. Balashov et al., “High resolution 3D microscopy study of cardiomyocytes on polymer scaffold nanofibers reveals formation of unusual sheathed structure,” Acta Biomaterialia, doi:10.1016/j.actbio.2017.12.031, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.